• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OXA-23 型碳青霉烯酶耐药鲍曼不动杆菌克隆复合体 22 在我国多个城市的广泛传播。

Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China.

机构信息

Department of Respiratory Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, People's Republic of China.

出版信息

J Antimicrob Chemother. 2010 Apr;65(4):644-50. doi: 10.1093/jac/dkq027. Epub 2010 Feb 12.

DOI:10.1093/jac/dkq027
PMID:20154023
Abstract

OBJECTIVES

In this study, multilocus sequence typing (MLST) was used to describe the genetic backgrounds of carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-susceptible A. baumannii (CSAB) from multiple cities of China.

METHODS

One hundred and fifty-two CRAB and 74 CSAB isolates obtained from 16 cities of China were selected for molecular characterization by MLST. eBURST was used to cluster sequence types (STs) into clonal complex (CCs) and infer evolutionary descent. PCR was used to detect carbapenemase-encoding genes and bla(AmpC) with the upstream element ISAba1.

RESULTS

CSAB showed more diverse genetic backgrounds than CRAB since 36 distinct STs were identified in CSAB while only 8 STs were identified in CRAB. ST22 and its three single-locus variants, all clustered into CC22, were the most prominent STs, accounting for 86.8% of CRAB and 45.9% of CSAB, distributed in all 16 cities and possessing more noticeable antibiotic resistance than other STs. PCR amplification was positive for bla(OXA-23) in most CRAB isolates but negative in CSAB isolates. The presence of ISAba1 upstream of bla(AmpC) was variable in distinct STs of CRAB. eBURST reveals that CC22 is the largest group in the Pubmlst database, which also contains ST6 previously identified in a European clone II isolate as a member of a subgroup of CC22.

CONCLUSIONS

We describe the wide dissemination of CRAB CC22 in China. The close relatedness between CC22 and European clone II implies the probable global spread of CC22. It is inferred that ST22-CSAB evolves to ST22-CRAB through acquiring bla(OXA-23) as a determinative factor.

摘要

目的

本研究采用多位点序列分型(MLST)方法描述中国多个城市耐碳青霉烯鲍曼不动杆菌(CRAB)和碳青霉烯敏感鲍曼不动杆菌(CSAB)的遗传背景。

方法

选择来自中国 16 个城市的 152 株 CRAB 和 74 株 CSAB 分离株进行分子特征分析,采用 MLST 将序列型(ST)聚类为克隆复合体(CC)并推断进化关系。PCR 检测碳青霉烯酶编码基因和 bla(AmpC),并带有上游元件 ISAba1。

结果

CSAB 的遗传背景比 CRAB 更为多样化,因为在 CSAB 中鉴定出 36 个不同的 ST,而在 CRAB 中仅鉴定出 8 个 ST。ST22 及其三个单一位点变体,均聚类到 CC22,是最主要的 ST,分别占 CRAB 的 86.8%和 CSAB 的 45.9%,分布于所有 16 个城市,其抗生素耐药性比其他 ST 更为显著。大多数 CRAB 分离株 bla(OXA-23)的 PCR 扩增呈阳性,但 CSAB 分离株呈阴性。CRAB 不同 ST 中 bla(AmpC)上游 ISAba1 的存在情况各不相同。eBURST 显示 CC22 是 Pubmlst 数据库中最大的群组,其中还包含之前在欧洲克隆 II 分离株中鉴定出的 ST6,作为 CC22 亚群的成员。

结论

我们描述了 CRAB CC22 在我国的广泛传播。CC22 与欧洲克隆 II 密切相关,暗示 CC22 可能在全球范围内传播。推断 ST22-CSAB 通过获得 bla(OXA-23)作为决定因素演变为 ST22-CRAB。

相似文献

1
Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China.OXA-23 型碳青霉烯酶耐药鲍曼不动杆菌克隆复合体 22 在我国多个城市的广泛传播。
J Antimicrob Chemother. 2010 Apr;65(4):644-50. doi: 10.1093/jac/dkq027. Epub 2010 Feb 12.
2
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.在捷克共和国,鲍曼不动杆菌对碳青霉烯类抗生素耐药性的出现与欧洲克隆II型多重耐药菌株的传播有关。
J Antimicrob Chemother. 2008 Sep;62(3):484-9. doi: 10.1093/jac/dkn205. Epub 2008 May 13.
3
Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China.中国西部欧洲克隆 II 型碳青霉烯类耐药鲍曼不动杆菌的传播。
Int J Antimicrob Agents. 2011 Sep;38(3):257-60. doi: 10.1016/j.ijantimicag.2011.04.015. Epub 2011 Jun 25.
4
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.意大利碳青霉烯类耐药鲍曼不动杆菌临床分离株的流行病学特征和分布。
Clin Microbiol Infect. 2012 Feb;18(2):160-6. doi: 10.1111/j.1469-0691.2011.03527.x. Epub 2011 Jul 1.
5
Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.从韩国医院分离出的两种不同的耐碳青霉烯鲍曼不动杆菌克隆株。
Diagn Microbiol Infect Dis. 2009 Aug;64(4):389-95. doi: 10.1016/j.diagmicrobio.2009.03.029.
6
Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.加拿大耐多药及耐碳青霉烯类鲍曼不动杆菌的鉴定:2007年加拿大抗菌药物耐药监测(CANWARD)结果
J Antimicrob Chemother. 2009 Sep;64(3):552-5. doi: 10.1093/jac/dkp225. Epub 2009 Jul 3.
7
Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.广泛分布的碳青霉烯类耐药和产 OXA-23 的鲍曼不动杆菌在中国多个省份。
Int J Antimicrob Agents. 2013 Oct;42(4):322-8. doi: 10.1016/j.ijantimicag.2013.06.019. Epub 2013 Aug 9.
8
Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.巴西南部库里蒂巴地区碳青霉烯类耐药鲍曼不动杆菌的时间演变。
Am J Infect Control. 2010 May;38(4):308-14. doi: 10.1016/j.ajic.2009.09.012. Epub 2010 Jan 31.
9
Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.临床鲍曼不动杆菌分离株中 OXA-66 向 OXA-82 的转化及其与碳青霉烯类药物敏感性改变的关系。
J Antimicrob Chemother. 2013 Feb;68(2):308-11. doi: 10.1093/jac/dks382. Epub 2012 Sep 26.
10
An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China.中国西部产OXA-23碳青霉烯酶的耐碳青霉烯鲍曼不动杆菌暴发。
Int J Antimicrob Agents. 2008 Jan;31(1):50-4. doi: 10.1016/j.ijantimicag.2007.08.019.

引用本文的文献

1
Virulence factors, molecular characteristics, and resistance mechanisms of carbapenem-resistant Pseudomonas aeruginosa isolated from pediatric patients in Shanghai, China.从中国上海儿科患者中分离出的耐碳青霉烯类铜绿假单胞菌的毒力因子、分子特征及耐药机制
BMC Microbiol. 2025 Mar 11;25(1):130. doi: 10.1186/s12866-025-03856-1.
2
Emergence of eravacycline heteroresistance in carbapenem-resistant isolates in China.厄他培南耐药碳青霉烯类耐药株中出现依拉环素异质性耐药。
Front Cell Infect Microbiol. 2024 Mar 27;14:1356353. doi: 10.3389/fcimb.2024.1356353. eCollection 2024.
3
Development and clinical validation of a dual ddPCR assay for detecting carbapenem-resistant in bloodstream infections.
一种用于检测血流感染中耐碳青霉烯类细菌的双重数字滴度PCR检测方法的开发与临床验证
Front Microbiol. 2024 Mar 5;15:1338395. doi: 10.3389/fmicb.2024.1338395. eCollection 2024.
4
Carbapenem-resistant gram-negative bacterial prevention practice in nosocomial infection and molecular epidemiological characteristics in a pediatric intensive care unit.儿科重症监护病房耐碳青霉烯类革兰阴性菌医院感染预防措施及分子流行病学特征
Heliyon. 2023 Aug 6;9(8):e18969. doi: 10.1016/j.heliyon.2023.e18969. eCollection 2023 Aug.
5
Insights into the Intersection of Biocide Resistance, Efflux Pumps, and Sequence Types in Carbapenem-Resistant : A Multicenter Study.碳青霉烯耐药菌中生物杀灭剂抗性、外排泵与序列类型交叉点的见解:一项多中心研究
Pathogens. 2023 Jun 30;12(7):899. doi: 10.3390/pathogens12070899.
6
Comparative Respiratory Tract Microbiome Between Carbapenem-Resistant Colonization and Ventilator Associated Pneumonia.耐碳青霉烯定植与呼吸机相关性肺炎患者呼吸道微生物群的比较
Front Microbiol. 2022 Mar 4;13:782210. doi: 10.3389/fmicb.2022.782210. eCollection 2022.
7
Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.多重耐药鲍曼不动杆菌在医院的新关注点。
Mol Biol Rep. 2021 Oct;48(10):6987-6998. doi: 10.1007/s11033-021-06690-6. Epub 2021 Aug 30.
8
Molecular characterization and antibiotic resistance of Acinetobacter baumannii in cerebrospinal fluid and blood.脑积液和血液中鲍曼不动杆菌的分子特征及耐药性分析。
PLoS One. 2021 Feb 22;16(2):e0247418. doi: 10.1371/journal.pone.0247418. eCollection 2021.
9
Molecular typing, and integron and associated gene cassette analyses in strains isolated from clinical samples.对从临床样本中分离出的菌株进行分子分型、整合子及相关基因盒分析。
Exp Ther Med. 2020 Sep;20(3):1943-1952. doi: 10.3892/etm.2020.8911. Epub 2020 Jun 19.
10
Emergence, molecular mechanisms and global spread of carbapenem-resistant .耐碳青霉烯肠杆菌科细菌的出现、分子机制和全球传播。
Microb Genom. 2019 Oct;5(10). doi: 10.1099/mgen.0.000306.